GLP-3 is a term increasingly used online for new weight-loss products. However, GLP-3 is not an official name like GLP-1. Usually, people mean a product that works on three hormone pathways when they say GLP-3.
The most well-known substance mentioned in this context is Retatrutide. Retatrutide is being investigated as a so-called triple agonist. This means it works on three receptors: GLP-1, GIP, and glucagon.
Within weight loss, this topic connects to resources such as GLP-1, Semaglutide, Ozempic and Mounjaro. The difference is that GLP-3 in practice usually refers to a newer generation of agents that work more broadly than just GLP-1.
GLP-3 is often used as a popular name for a new generation of weight-loss drugs. The term became particularly well-known through online discussions about Retatrutide.
Strictly speaking, GLP-3 is not the same as GLP-1. GLP-1 is a naturally occurring hormone that affects appetite, satiety, gastric emptying, and blood sugar. GLP-3 is usually used as a collective term for agents that affect multiple pathways simultaneously.
The correct explanation is therefore: GLP-3 is not a standard hormone name, but a search term that often refers to triple agonists. These agents are being investigated for overweight, obesity, and type 2 diabetes.
A triple agonist works through three different pathways. In the case of Retatrutide, these are GLP-1, GIP, and glucagon. These three hormone pathways play a role in appetite, satiety, blood sugar, and energy expenditure.
GLP-1 primarily aids in satiety. It can cause someone to feel full faster. It also slows down gastric emptying. This keeps food in the stomach longer and can reduce cravings.
GIP plays a role in insulin, blood sugar, and energy processing. This pathway is also known from Mounjaro. Mounjaro works via GLP-1 and GIP.
Glucagon is the third pathway. This hormone is involved in energy release. It helps the body make stored energy available. Therefore, glucagon is interesting in research on weight loss and metabolism.
The difference lies mainly in the number of pathways a substance acts on. GLP-1-medications primarily work via the GLP-1 receptor. Examples include Semaglutide and Ozempic.
Mounjaro works via two pathways: GLP-1 and GIP. Therefore, tirzepatide is often called a dual agonist.
Retatrutide works via three pathways: GLP-1, GIP, and glucagon. Therefore, it is called a triple agonist. Online, it is sometimes referred to as GLP-3 because of its three mechanisms of action.
GLP-3 is being discussed because triple agonists can influence multiple aspects of weight loss. They can affect appetite, satiety, blood sugar, and energy expenditure.
For many overweight people, appetite plays a big role. The body then sends strong signals to eat. Medications that act on GLP-1 can reduce these signals.
With a triple agonist, there's more to it. The combination with GIP and glucagon makes the subject interesting for research into weight loss and metabolic health.
Reuters reported in 2026 that retatrutide resulted in significant reductions in blood sugar and weight in a late-stage diabetes trial. According to the report, the drug acts on GLP-1, GIP, and glucagon, and belongs to the new group of “triple-G” agents.
Retatrutide is the name most often associated with GLP-3. It is an experimental agent being studied for weight loss and type 2 diabetes.
Retatrutide does not mimic one hormone pathway, but three. Because of this, it is seen as a next step after GLP-1 medications and dual-action medications like tirzepatide.
The potential positive effects discussed are reduced appetite, feeling full faster, weight loss, and improved blood sugar levels. This makes Retatrutide interesting for people seeking the latest developments in medical weight loss support.
At the same time, it's important to know that Retatrutide is not yet the same as a regularly available weight-loss medication. Research is still being conducted on its mechanism of action, dosage, safety, and long-term effects.
Interest in GLP-3 is primarily due to its broad mechanism of action. Because triple agonists affect multiple pathways simultaneously, they are often discussed as the next generation of weight-loss drugs.
Possible positive effects often mentioned include:
For many people, the effect on appetite is particularly important. When cravings decrease, it often becomes easier to eat fewer calories. This can help with weight loss.
The influence on blood sugar is also important. More stable blood sugar levels can help with understanding energy and appetite. This is particularly relevant for people with insulin resistance or type 2 diabetes.
Athletes can also look for GLP-3. This often relates to weight loss, body composition, and fat mass. Weight sometimes plays a role, particularly in bodybuilding, running, cycling, and triathlon.
However, it is important for athletes to look beyond just kilograms. Muscle mass, energy, recovery, and performance are at least as important.
If appetite decreases significantly, someone may also not be getting enough protein or carbohydrates. This can affect training and recovery. Therefore, weight loss in athletes must always be well-planned.
Muscle preservation is important for strength athletes. Sufficient fuel around workouts is important for endurance athletes. GLP-3 therefore logically fits into a broader plan with nutrition, training, and guidance.
GLP-3 is sometimes seen as a weight loss agent or fat burner. However, it works differently than classic fat burners.
A fat burner is often associated with stimulation, caffeine, thermogenesis, or energy expenditure. GLP-3 primarily works through hormonal pathways that influence appetite, satiety, blood sugar, and metabolism.
This is why GLP-3 is more suited for medical weight loss support than for regular supplements. Those who want to understand the difference can also visit the page about fatburners read.
Semaglutide is a GLP-1 receptor agonist. It primarily works via GLP-1. Ozempic is a well-known brand name for semaglutide.
Mounjaro contains tirzepatide. Tirzepatide works via GLP-1 and GIP. Therefore, Mounjaro is often discussed as the next step after agents that only work on GLP-1.
Retatrutide's GLP-3 takes it a step further. It is being discussed because it works via GLP-1, GIP, and glucagon. This is generating a lot of interest in its potential effects on appetite, weight, blood sugar, and energy processing.
Because GLP-3 usually refers to experimental triple agonists, good information is important. The agents are still being researched.
This means that not everything is known about the long term, dosage, and broad application.
Just like with GLP-1 drugs, gastrointestinal side effects can occur. These include nausea, diarrhea, constipation, vomiting, or a feeling of fullness. Reuters mentioned nausea, diarrhea, and vomiting as reported side effects in a late-stage trial of Retatrutide, among others.
There is also a lot of online availability of products that present themselves as new slimming aids. This calls for extra attention. Products outside of official medical channels can be incorrectly dosed, impure, or not genuine. Recent reports warn that Retatrutide, despite significant online attention, is not yet available as a regular slimming aid and that counterfeit products pose risks.
Are you taking medication? Do you have diabetes, gastrointestinal issues, or other health problems? Always discuss this topic with a doctor or expert.
GLP-3 is particularly interesting for people who want to learn more about the latest developments in medical weight loss support. The topic is relevant for people who are already searching for GLP-1, Semaglutide, Ozempic, Mounjaro, or Retatrutide.
The topic can also be interesting for athletes. This primarily concerns body composition, fat loss, and performance maintenance. However, guidance remains important.
GLP-3 is not a basic step. It is a new and specialized topic. Therefore, always start with a good explanation of GLP-1 and the well-known methods within this theme.
GLP-3 is not an official standard name like GLP-1. The term is often used online for triple agonists. This usually refers to Retatrutide.
Retatrutide works on three hormone pathways: GLP-1, GIP, and glucagon. As a result, it is discussed in relation to appetite, satiety, blood sugar, energy processing, and weight loss.
The difference with Semaglutide is that semaglutide primarily works via GLP-1. The difference from Mounjaro is that Mounjaro works via GLP-1 and GIP. GLP-3 or Retatrutide is discussed as a triple agonist.
The potential benefits primarily lie in reduced cravings, increased satiety, better blood sugar regulation, and weight loss. Points of attention include gastrointestinal complaints, nutrition, medical guidance, and the risk of unreliable online products.
A good choice starts with good information. Therefore, always read carefully what a product does. Also pay attention to possible risks.
Are you doubting? Then seek advice from an expert.
GLP-3 is not an official standard name like GLP-1. Online, GLP-3 is often used for agents that work on three hormone pathways.
Usually, people mean Retatrutide or a triple agonist.
In many online searches, GLP-3 is used to refer to Retatrutide.
The better term is triple agonist. Retatrutide works on GLP-1, GIP, and glucagon.
GLP-3 usually refers to a drug that acts on three pathways.
GLP-1 influences satiety and gastric emptying.
GIP plays a role in insulin and energy processing.
Glucagon is involved in energy release.
GLP-1 refers to one hormone pathway.
GLP-3 is often used online for agents that affect three pathways.
This usually involves GLP-1, GIP, and glucagon.
Mounjaro works via two pathways: GLP-1 and GIP.
GLP-3 of Retatrutide is discussed as a triple agonist.
This means there are three pathways involved: GLP-1, GIP, and glucagon.
No.
GLP-3 does not work like a classic fat burner.
The mechanism is mainly linked to appetite, satiety, blood sugar, and metabolism.
GLP-3 is often discussed in relation to reduced appetite, feeling full faster, better control over eating, blood sugar regulation, and weight loss.
The precise effects depend on the substance and the person.
For athletes, GLP-3 may seem interesting for fat loss and body composition.
Still, guidance is important.
Athletes should pay attention to sufficient protein, energy, recovery, and muscle maintenance.
Dutch Dutch 
English
